In the last trading session, 4.49 million Biocryst Pharmaceuticals Inc (NASDAQ:BCRX) shares changed hands as the company’s beta touched 1.09. With the company’s per share price at $10.33 changed hands at -$0.04 or -0.39% during last session, the market valuation stood at $2.16B. BCRX’s last price was a discount, traded about -7.55% off its 52-week high of $11.11. The share price had its 52-week low at $5.92, which suggests the last value was 42.69% up since then.
Analysts gave the Biocryst Pharmaceuticals Inc (BCRX) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.17. If we narrow down to specifics, the data shows that 0 out of 13 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 2 recommended BCRX as a Hold, 11 felt it is a Buy and 0 rated the stock as Underweight.
Biocryst Pharmaceuticals Inc (NASDAQ:BCRX) trade information
Instantly BCRX was in red as seen at the end of in last trading. With action 2.68%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 37.37%, with the 5-day performance at 2.68% in the green. However, in the 30-day time frame, Biocryst Pharmaceuticals Inc (NASDAQ:BCRX) is 37.18% up.
The consensus price target for the stock as assigned by Wall Street analysts is 16, meaning bulls need an upside of 35.44% from its current market value. According to analyst projections, BCRX’s forecast low is 7 with 25 as the target high. To hit the forecast high, the stock’s price needs a -142.01% plunge from its current level, while the stock would need to tank 32.24% for it to hit the projected low.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 14.52%. The 2025 estimates are for Biocryst Pharmaceuticals Inc earnings to increase by 132.67%.
BCRX Dividends
Biocryst Pharmaceuticals Inc is expected to release its next quarterly earnings report in June.
VANGUARD GROUP INC holds the second largest percentage of outstanding shares, with 9.0926% or 18.77 million shares worth $116.0 million as of 2024-06-30.
Among Mutual Funds, the top two as of Dec 31, 2024 were VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF . With 6.5 shares estimated at $67.1 million under it, the former controlled 3.10% of total outstanding shares. On the other hand, iShares Trust-iShares Russell 2000 ETF held about 2.59% of the shares, roughly 5.43 shares worth around $56.05 million.
